Pattern of presentation and outcome of surgical management of primary open angle glaucoma in Kano, Northern Nigeria

Annals of African Medicine

Volumn 6, Issue 4, 2007, Pages 180-185

  Lawan, Abdu ^a,b  

^a BAYERO UNIVERSITY   (Nigeria)

^b AMINU KANO TEACHING HOSPITAL   (Nigeria)

Author keywords

Avoidable blindness; Glaucoma; Late presentation; tTrabeculectomy

Indexed keywords

DEXAMETHASONE; FLUOROURACIL; LOMEFLOXACIN; TROPICAMIDE; ANTIMETABOLITE;

ADULT; AGED; ANTERIOR EYE CHAMBER ANGLE; ARTICLE; BLINDNESS; CONTROLLED STUDY; EXTRACAPSULAR CATARACT EXTRACTION; EYE FIXATION; FEMALE; GONIOSCOPY; HUMAN; INFORMATION RETRIEVAL; INTRAOCULAR PRESSURE; LENS IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NIGERIA; OCULOPLETHYSMOGRAPHY; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PERIMETRY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SCOTOMA; THERAPY EFFECT; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; AGE DISTRIBUTION; MIDDLE AGED; SEX RATIO; TIME; VISION TEST;

ADULT; AGE DISTRIBUTION; AGED; ANTIMETABOLITES; BLINDNESS; FEMALE; FLUOROURACIL; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; NIGERIA; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; TIME FACTORS; TREATMENT OUTCOME; VISION TESTS;

EID: 43549119787     PISSN: 15963519     EISSN: None     Source Type: Journal    
DOI: 10.4103/1596-3519.55700     Document Type: Article

References (44)

1. Kansky JJ. Clinical ophthalmology. Third edition. Butterworth-Heinemann 1997: 267-273.
2. Butcher PJ, Ijsselmuiden CB. Prevalence and causes of blindness in the northern Transvaal. Br J Ophthalmol. 1988;72:721-726.
3. Chirambo MC, Schwab L. Ophthalmology in Malawi. Arch Ophthalmol. 1989;107:1826-1829.
4. Fafowora OF, Oshuntokun OO. Age related disease in the elderly members of rural African community. East Afr Med J. 1997;74:435-437.
5. Abdu L. Prevalence and cause of blindness and loW vision in Dambatta local government area, Kano state, Nigeria. Niger J Med. 2002;11:108-112.
6. Laske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol. 1994;112:821-829.
7. Manual of international statistical classification of diseases injuries and causes of death. Geneva. 1977; 46.
8. Bachman JA. Juvenile onset primary open angle glaucoma; three case studies and review. J Am Optom Assoc. 1998;69:785-795.
9. Feid ME, Krupin T. Juvenile glaucoma, in Fraunfelder FT, Roy FH (Eds). Ocular therapy. Philadelpia, WB Saunders Co 1995, pp. 640-643.
10. Schwab L, Kagame K. Blindness in Africa: Zimbabwe school for the blind survey. Br J Ophthalmol. 1993;77:410-412.
11. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
12. Mason RP, Kosoko O, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part 1. Prevalence findings. Ophthalmology. 1989;96:1363-1368.
13. Wilson R, Richardson TM, Hertzmark E, Grant WM. Race as a risk factor for progressive glaucomatous damage. Ann Ophthalmol. 1985;17:653-659.
14. Sommer A, Tielsch JM, Katz J, et al. Relationship between intra ocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol. 1991;109:1090-1095.
15. Wallace J, Lovell HG. Glaucoma and intraocular pressure in Jamaica. Am J Ophthalmol. 1969;67:93-100.
16. Alward WL. The genetics of open angle glaucoma: the story of GLCIA and myocilin. Eye. 2000;14:429-436.
17. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99:635-649.
18. Chi T, Ritch R. Stickler D, et al. Racial differences in optic nerve parameters. Arch Ophthalmol. 1989;107:836-839.
19. Mansour AM. Racial variation of optic disc size. Ophthalmic Res. 1991;23:67-72.
20. Quigley HA, Brown AE, Morrison JD, Drance SM. The size and shape of optic disc in normal human eyes. Arch Ophthalmol. 1990;108:51-57.
21. Martin MJ, Sommer A, Gold EB, Diamond EL. Race and primary open angle glaucoma. Am J Ophthalmol. 1985;99:383-387.
22. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalomol 1991; 1090-1095.
23. Rubin GS, West SK, Munoz B, et al. a comprehensive assessment of visual impairment in a population of older Americans. The SEE study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci. 1997;38:557-568.
24. American Academy of Ophthalmology. Glaucoma in basic clinical science course (section 10). San Francisco, American Academy of Ophthalmology; 2001 pg:11.
25. Shin DH, Becker B, Kolker AE. Family history in primary open angle glaucoma. Arch Ophthalmol. 1977;95:598-600.
26. Curtin B. The Myopias. Basic Science and Clinical Management Philadelphia, Harper and Row, 1985 pp. 64.
27. Jonas JB, Gusek GC, Naumann GO. Optic disc morphometry in high myopia. Graefes Arch Clin Exp Ophthalmol. 1988;226:587-590.
28. Benson WE, Brown GC, Tasman W. Diabetes and its ocular complications. Philadelphia. WB Saunders, 1988 pp: 67.
29. Tiesch JM, Katz J, Sommer A et al. Hypertension, perfusion pressure and primary open angle glaucoma. A population based assessment. Arch Ophthatmol. 1995; 113:216-221.
30. Leske MC, Wu SY, Nemesure B, Hennis A. Incident open angle glaucoma and blood pressure. Arch Ophthalmol. 2002;120:954-959.
31. Lawson WB. Clinical issues in pharmacotherapy of African Americans. Psychopharmacol Bull. 1996;32:275-281.
32. Lawson WB. The art and science of the psycho pharmacotherapy of African-Americans. Mt Sinai J Med. 1996;63:301-305.
33. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma. Arch Ophthalmol. 2002;120:829-830.
34. Olateju SO, Ajayi AA. The lack of efficacy of beta-blockers, timolol and betaxotol on intraocular pressure in Nigerian healthy volunteers. Eye. 1999;13:758-763.
35. Katz IM, Hubbard WA, Getson AJ, Gould AL. Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol. 1976;15:489-492.
36. Leblanc B, Jezquel S, Davies T, et al. Binding of drugs to eye melanin is not predictive of ocular toxicity. Regul Toxicol Pharmacol. 1998;28:124-132.
37. Eghert PR. Glaucoma in West Africa: A neglected problem. Br J Ophthalmol. 2002;86:131-132.
38. Silva JC, Bateman JB, Contreras F. Eye disease and care in Latin American and the Caribbean. Surv Ophthalmol. 2002;47:267-274.
39. Lewallen S, Courtright P. Blindness in Africa: Present situation and future needs. Br J Ophthalmol. 2001;85:897-903.
40. Schwab L, Steinkuller PG. Surgical treatment of open angle glaucoma is preferable to medical management in Africa. Soc Sci Med. 1983;17:1723-1727.
41. AGIS. The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven year results. Ophthalmology. 1998;105:1146-1164.
42. The Fluorouracil Filtering Surgery Study Group. Fluorouracil filtering surgery study, one year follow up. Am J Ophthalmol. 1989;108:625-635.
43. Schwartz AL, Love DC, Schwartz MA. Long term follow up of Argon laser trabeculoplasty for uncontrolled open angle glaucoma. Arch Ophthalmol. 1985;103:1482-1484.
44. AGIS. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within. treatment groups. Am J Ophthalmol. 2001;132:311-320.